Literature DB >> 1867478

Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases.

H Akamatsu1, J Komura, Y Asada, Y Miyachi, Y Niwa.   

Abstract

It has been shown that acne, hyperpigmentation and lentigo malignant are more or less related pathogenetically to reactive oxygen species (ROS). It has recently been reported that azelaic acid is effective in treating these conditions and that it possesses anti-enzymatic and antimitochondrial activity, including cytochrome-P450 reductase and 5 alpha-reductase in microsomal preparations with nicotinamide adenine dinucleotide phosphate (NADPH). We therefore investigated the effects of azelaic acid on human neutrophil functions, such as chemotaxis, phagocytosis and ROS generation. ROS generation in a cell-free system was also assessed. The results revealed that neutrophil chemotaxis and phagocytosis as well as ROS generated in a xanthine-xanthine-oxidase system were not significantly changed in the presence of azelaic acid. However, azelaic acid markedly decreased O2- and OH. generated by neutrophils. It may be concluded that the reported clinical effectiveness of azelaic acid is partly due to its inhibitory action on neutrophil-generated ROS, leading to a reduction both in oxidative tissue injury at sites of inflammation and in melanin formation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1867478     DOI: 10.1007/bf00372056

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  41 in total

1.  The effect of superoxide dismutase and catalase on radiation-induced chromosome breaks.

Authors:  I Nordenson; G Beckman; L Beckman
Journal:  Hereditas       Date:  1976       Impact factor: 3.271

2.  Topical azelaic acid and the treatment of acne: a clinical and laboratory comparison with oral tetracycline.

Authors:  P T Bladon; B M Burke; W J Cunliffe; R A Forster; K T Holland; K King
Journal:  Br J Dermatol       Date:  1986-04       Impact factor: 9.302

3.  Evaluation of opsonic and leukocyte function with a spectrophotometric test in patients with infection and with phagocytic disorders.

Authors:  T P Stossel
Journal:  Blood       Date:  1973-07       Impact factor: 22.113

4.  Difference in susceptibility to injury by linoleic acid hydroperoxide between endothelial and smooth muscle cells of arteries.

Authors:  Y Sasaguri; M Morimatsu; T Kinoshita; T Nakashima; T Inagaki; K Yagi
Journal:  J Appl Biochem       Date:  1985-02

5.  Inhibition of tumor promotion by a biomimetic superoxide dismutase.

Authors:  T W Kensler; D M Bush; W J Kozumbo
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

6.  Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.

Authors:  Y Niwa; S Miyake; T Sakane; M Shingu; M Yokoyama
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

7.  Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.

Authors:  A R Johnson; E G Erdös
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

8.  H2O2 release from human granulocytes during phagocytosis. Relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B-treated cells.

Authors:  R K Root; J A Metcalf
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

9.  [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures].

Authors:  G Geier; T Hauschild; R Bauer; H W Kreysel
Journal:  Hautarzt       Date:  1986-03       Impact factor: 0.751

10.  An evaluation of the effectiveness of azelaic acid as a depigmenting and chemotherapeutic agent.

Authors:  M A Pathak; E R Ciganek; M Wick; A J Sober; W A Farinelli; T B Fitzpatrick
Journal:  J Invest Dermatol       Date:  1985-09       Impact factor: 8.551

View more
  24 in total

Review 1.  Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2017-03-01

2.  Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice.

Authors:  Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi; Larissa Brophy; Sampath Parthasarathy
Journal:  Atherosclerosis       Date:  2009-10-12       Impact factor: 5.162

3.  A Novel Mechanism for Atherosclerotic Calcification: Potential Resolution of the Oxidation Paradox.

Authors:  Aladdin Riad; Chandrakala Aluganti Narasimhulu; Pragney Deme; Sampath Parthasarathy
Journal:  Antioxid Redox Signal       Date:  2018-01-24       Impact factor: 8.401

Review 4.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

5.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

Review 6.  Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.

Authors:  A Fitton; K L Goa
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

7.  In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome.

Authors:  Michael Maes; Buranee Kanchanatawan; Sunee Sirivichayakul; André F Carvalho
Journal:  Mol Neurobiol       Date:  2018-11-27       Impact factor: 5.590

8.  Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis.

Authors:  Achuthan Raghavamenon; Mahdi Garelnabi; Sainath Babu; Alex Aldrich; Dmitry Litvinov; Sampath Parthasarathy
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

Review 9.  Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.

Authors:  Sampath Parthasarathy; Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi
Journal:  Biochim Biophys Acta       Date:  2008-03-25

Review 10.  The molecular pathology of rosacea.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  J Dermatol Sci       Date:  2009-05-29       Impact factor: 4.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.